Company Profile
Kangstem Biotech Co., Ltd. a biopharmaceutical company develops stem cell therapeutic products for rare and incurable diseases. The company's stem cell therapy products include Furestem-AD for treatment of subacute and chronic atopic dermatitis.
Its portfolio also includes Furestem-RA to treat rheumatoid arthritis, and Furestem-CD for treatment of active crohn's disease Stem cell conditioned media, such as umbilical cord blood-derived stem cell conditioned media that includes epidermal, vascular endothelium, keratinocyte, hepatocyte, transforming, and platelet-derived growth factors
Growth and differentiation factor 11, and Fibroblast growth factor 2 for skin growth and regeneration. Additionally, it offers stem cell culture media, including KSB-3 kit, a medium for culturing the human mesenchymal stem cell; and cell freezing and thawing platform Pharmaceutical contract manufacturing and development services. Founded in 2010, Kangstem Biotech is headquartered in Seoul, South Korea.